Interruption of vascular thrombosis by bolus anti-platelet glycoprotein IIb/IIIa monoclonal antibodies in baboons
- 1 February 1993
- journal article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 17 (2) , 294-304
- https://doi.org/10.1016/0741-5214(93)90415-i
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Antiplatelet monoclonal F(ab′)2 antibody directed against the platelet GPIIb/IIIa receptor complex prevents coronary artery thrombosis in the canine heartJournal of Molecular and Cellular Cardiology, 1989
- Clinical Implications of Prostaglandin and Thromboxane A2FormationNew England Journal of Medicine, 1988
- Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary AngioplastyNew England Journal of Medicine, 1988
- Platelet membrane glycoprotein changes during the preparation and storage of platelet concentratesTransfusion, 1988
- Secondary prevention of vascular disease by prolonged antiplatelet treatmentBMJ, 1988
- Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon.Journal of Clinical Investigation, 1988
- The Platelet Membrane Glycoprotein IIb/IIIa ComplexAnnals of the New York Academy of Sciences, 1987
- Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody.Journal of Clinical Investigation, 1985
- Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition.Journal of Clinical Investigation, 1985
- Molecular Defects in Interactions of Platelets with the Vessel WallNew England Journal of Medicine, 1984